These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30591442)

  • 1. Detection of Pancreatic Cancer by Urine Volatile Organic Compound Analysis.
    Nissinen SI; Roine A; Hokkinen L; Karjalainen M; Venäläinen M; Helminen H; Niemi R; Lehtimäki T; Rantanen T; Oksala N
    Anticancer Res; 2019 Jan; 39(1):73-79. PubMed ID: 30591442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Invasive Diagnosis of Diabetes by Volatile Organic Compounds in Urine Using FAIMS and Fox4000 Electronic Nose.
    Esfahani S; Wicaksono A; Mozdiak E; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2018 Dec; 8(4):. PubMed ID: 30513787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.
    Arasaradnam RP; McFarlane MJ; Ryan-Fisher C; Westenbrink E; Hodges P; Thomas MG; Chambers S; O'Connell N; Bailey C; Harmston C; Nwokolo CU; Bardhan KD; Covington JA
    PLoS One; 2014; 9(9):e108750. PubMed ID: 25268885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAIMS analysis of urine gaseous headspace is capable of differentiating ovarian cancer.
    Niemi RJ; Roine AN; Eräviita E; Kumpulainen PS; Mäenpää JU; Oksala N
    Gynecol Oncol; 2018 Dec; 151(3):519-524. PubMed ID: 30257785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine.
    Arasaradnam RP; Wicaksono A; O'Brien H; Kocher HM; Covington JA; Crnogorac-Jurcevic T
    Gastroenterology; 2018 Feb; 154(3):485-487.e1. PubMed ID: 29129714
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-invasive distinction of non-alcoholic fatty liver disease using urinary volatile organic compound analysis: early results.
    Arasaradnam RP; McFarlane M; Daulton E; Westenbrink E; O'Connell N; Wurie S; Nwokolo CU; Bardhan KD; Savage RS; Covington JA
    J Gastrointestin Liver Dis; 2015 Jun; 24(2):197-201. PubMed ID: 26114180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine headspace analysis with field asymmetric ion mobility spectrometry for detection of chronic kidney disease.
    Jokiniitty E; Hokkinen L; Kumpulainen P; Leskinen Y; Lehtimäki T; Oksala N; Roine A
    Biomark Med; 2020 Jun; 14(8):629-638. PubMed ID: 32613848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-analytical and analytical variables that influence urinary volatile organic compound measurements.
    McFarlanE M; MozdiaK E; Daulton E; Arasaradnam R; Covington J; Nwokolo C
    PLoS One; 2020; 15(7):e0236591. PubMed ID: 32735600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease.
    Arasaradnam RP; Ouaret N; Thomas MG; Quraishi N; Heatherington E; Nwokolo CU; Bardhan KD; Covington JA
    Inflamm Bowel Dis; 2013 Apr; 19(5):999-1003. PubMed ID: 23478806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
    Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
    Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VOC-based detection of prostate cancer using an electronic nose and ion mobility spectrometry: A novel urine-based approach.
    Heers H; Chwilka O; Huber J; Vogelmeier C; Koczulla AR; Baumbach JI; Boeselt T
    Prostate; 2024 Jun; 84(8):756-762. PubMed ID: 38497426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study for bladder cancer detection with volatile organic compounds using ion mobility spectrometry: a novel urine-based approach.
    Heers H; Gut JM; Hofmann R; Flegar L; Derigs M; Huber J; Baumbach JI; Koczulla AR; Boeselt T
    World J Urol; 2024 May; 42(1):353. PubMed ID: 38795133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volatile Organic Compounds in Urine for Noninvasive Diagnosis of Malignant Biliary Strictures: A Pilot Study.
    Navaneethan U; Parsi MA; Lourdusamy D; Grove D; Sanaka MR; Hammel JP; Vargo JJ; Dweik RA
    Dig Dis Sci; 2015 Jul; 60(7):2150-7. PubMed ID: 25708900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile-volatile organic compounds in the diagnostics of pancreatic cancer and biliary obstruction: A prospective proof-of-concept study.
    Teränen V; Nissinen S; Roine A; Antila A; Siiki A; Vaalavuo Y; Kumpulainen P; Oksala N; Laukkarinen J
    Front Oncol; 2022; 12():918539. PubMed ID: 36479080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.
    McFarlane M; Millard A; Hall H; Savage R; Constantinidou C; Arasaradnam R; Nwokolo C
    Colorectal Dis; 2019 Nov; 21(11):1259-1269. PubMed ID: 31282600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Invasive Detection of Anastomotic Leakage Following Esophageal and Pancreatic Surgery by Urinary Analysis.
    Plat VD; van Gaal N; Covington JA; Neal M; de Meij TGJ; van der Peet DL; Zonderhuis B; Kazemier G; de Boer NKH; Daams F
    Dig Surg; 2019; 36(2):173-180. PubMed ID: 29909416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved machine learning pipeline for urinary volatiles disease detection: Diagnosing diabetes.
    Martinez-Vernon AS; Covington JA; Arasaradnam RP; Esfahani S; O'Connell N; Kyrou I; Savage RS
    PLoS One; 2018; 13(9):e0204425. PubMed ID: 30261000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volatile organic compounds (VOCs) for the non-invasive detection of pancreatic cancer from urine.
    Daulton E; Wicaksono AN; Tiele A; Kocher HM; Debernardi S; Crnogorac-Jurcevic T; Covington JA
    Talanta; 2021 Jan; 221():121604. PubMed ID: 33076134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.
    Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ
    Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.